FridayAug 01, 2008 11:07 am

Immunomedics Inc. (IMMU) Releases Promising Results of Published Leukemia Study

According to the American Cancer Society, approximately 3,040 children will be diagnosed with Acute Lymphoblastic Leukemia (ALL) in the United States this year. While the five-year survival rate for ALL in children is 87 percent, the prognosis for a child with relapsed ALL remains low. These harrowing statistics are pushing biopharmaceutical companies to continue to improve research efforts for the treatment of ALL. Immunomedics Inc. (Nasdaq: IMMU) is a biopharmaceutical company focused on the development of monoclonal antibodies for the treatment of cancer, autoimmune and other serious diseases. Utilizing its proprietary technologies, the company has created a pipeline of therapeutic…

Continue Reading

FridayAug 01, 2008 11:06 am

Boyd Gaming Corp. (BYD) Pops 20% on Earnings, Project Delay, Stock Buyback

Shares of Boyd Gaming Corp. (BYD), a domestic casino operator with properties in six states, are trading 20% higher today after announcing Q2 financial results and the suspension of plans to begin construction of a huge Las Vegas development that investors feared would strain Boyd’s capital position. The company also announced the authorization of a $100-million share repurchase program. On the earnings front, Boyd reported net income excluding non-recurring items of $26.4 million, or 30 cents per share, vs. analysts’ estimates of 27 cents per share. Net revenues of $460.8 million were slightly below consensus of $462.9 million. Keith Smith,…

Continue Reading

FridayAug 01, 2008 7:27 am

Derma Sciences Inc. (DSCI.OB) Signs Major Distribution Deal for its MEDIHONEY Wound Care Product

Selling into any market with a large bureaucracy is a daunting and sometime frustrating task. Regulations and approvals seem to be waiting at every turn as a product wends its way through the process. If, however, a company can make it through the morass, a very shiny pot of gold can be waiting on the other side. Finding a company that has made it to the other side is a sure way to make a tidy profit. Derma Sciences Inc., a fully integrated manufacturer, marketer and supplier of wound and burn care products, works to develop and market products that…

Continue Reading

FridayAug 01, 2008 7:25 am

Gulfport Energy Corp. (GPOR) is Focused on Exploiting Core Producing Acreages

Based in Oklahoma City, Oklahoma, Gulfport Energy is a growth-oriented oil and gas exploration and production company. Trading on the NASDAQ, with a current market capitalization of $613.87M, the company's principal producing properties are located along the Louisiana Gulf Coast. Other areas that the company operates in are the Permian Basin and the Bakken/Williston Basin, the Alberta oil sands in Canada, and natural gas areas in northern Thailand. The company also involves itself in oil and gas exploration activities in Belize. Gulfport's Southern Louisiana assets consist of the West Cote Blanche Bay and Hackberry fields of approximately 12,000 acres in…

Continue Reading

FridayAug 01, 2008 7:19 am

Eden Energy Inc. (EDNE.OB) Plans Additional Gas Production by 4th Quarter

The harsh reality of getting a job done successfully is often lost on most consumers and investors. The end result and the immediate gratification that goes along with it is all that people really care about. Before a product gets to the consumer, however, quite a bit of hard work and frustration must be dealt with and overcome. Ultimately, if a product has value, the hardships faced are worth the effort and a solid product results. A company that can make it through these hardships is a company that will offer the ultimate rewards any investor is looking for. Eden…

Continue Reading

FridayAug 01, 2008 7:16 am

DelSite, Inc. (DSII.OB) Changes Trading Symbol & Sells Wound Care Division

Effective today, DelSite, Inc., a drug and vaccine delivery technology company, has changed its stock symbol and has announced that the company’s shares will no longer be trading under the symbol CARN.OB and will now trade on the OTCBB under the new symbol, DSII.OB. Changing the company’s symbol follows the company’s name change from Carrington Laboratories, Inc. on June 30, 2008, pursuant to shareholder approval on June 26, 2008. DelSite also announced today that the board of directors has made a decision to enter into an agreement to sell its Carrington® wound care division and all its trademarks and related…

Continue Reading

FridayAug 01, 2008 7:14 am

Simcere Pharmaceutical Group (SCR) is Dedicated to Innovative Research and Development

Simcere Pharmaceutical Group is furthering its position in the rapidly growing China market. Headquartered in Nanjing, China, it is a manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals. As part of the Drug Manufacturing industry, it concentrates research and development on the treatment of diseases with high incidences and/or mortality rates. Shares trade on the New York Stock Exchange. Simcere is focusing on drug medications for cancer, strokes, infectious diseases, and osteoporosis. They have introduced an anti-stroke medication under the brand name Bicun. They have also introduced an anti-cancer medication under the brand name Endu. The company makes…

Continue Reading

FridayAug 01, 2008 3:52 am

Which Small Capital Stocks Will Graduate to the Big League? A Series on Treasured Investing Tactics for Today

Unfortunately, there is no single route to success in business and stock investing. Sometimes, entirely contradictory approaches produce equally creditable results. The ‘specialization versus integration’ debate is an example. Some of the world’s best corporations remain sharply focused on a narrow business definition. Others build value for their stocks through horizontal integration. Customers are best placed to determine the optimal focal length of business scope. Careful analysis of a decision-making model can reveal how broad a range of products and services should be. A vegetable market cannot specialize in tomatoes alone. However, an expectant mother would hardly care to visit…

Continue Reading

FridayAug 01, 2008 3:49 am

How to Grow a Business & Stock Investment Mind – The Productive Week-End Series

These are great times for top stock investors to forge ahead. Business management professionals can use the current market environment just as well. Adversity brings out the best in the skilled and talented. Darwin’s Law applies to business and stocks: only the best will adapt to challenges and survive. Credit has become a competition driver in 2008. The best of Wall Street has crashed because they splurged their dollars. Untold numbers are in grief because budgeting illiteracy has brought wolves to their home doors. Big business, if the Fed is to be believed, is in danger if interest rates do…

Continue Reading

FridayAug 01, 2008 3:45 am

Gardner Denver, Inc. (GDI) Set to Acquire CompAir

Gardner Denver, Inc. (GDI) is a global manufacturer of highly engineered reciprocating, rotary and van compressors, liquid ring pumps and blowers for various industrial and transportation applications, pumps used in the petroleum and industrial markets, and other fluid transfer equipment serving chemical, petroleum and food industries. The company’s operations are organized into two reportable segments: Compressor and Vacuum Products, and Fluid Transfer Products. In the Fluid Transfer Products segment, the company designs, manufacturers, markets and services a diverse group of pumps, water jetting systems and related aftermarket parts used in oil and natural gas well drilling. In the Compressor and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered